5-(2R)-2-Oxiranyl-8-Benzyloxy-2(1H)-Quinolinone CAS 173140-90-4 Indacaterol Maleate Intermediate Purity >98.0% (HPLC)

Short Description:

Name: 5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-Quinolinone

Synonyms: 8-Benzoxy-5-(R)-Oxiranyl-1H-Quinolin-2-One

CAS: 173140-90-4

Appearance: Pale Yellow to Off-White Powder

Purity: >98.0% (HPLC) 

Intermediate of Indacaterol Maleate (CAS: 753498-25-8) in the treatment of COPD 

Contact: Dr. Alvin Huang  

Mobile/Wechat/WhatsApp: +86-15026746401   

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Chemical Properties:

Chemical Name 5-(2R)-2-Oxiranyl-8-Benzyloxy-2(1H)-Quinolinone
Synonyms 8-Benzoxy-5-(R)-Oxiranyl-1H-Quinolin-2-One
CAS Number 173140-90-4
CAT Number RF-PI127
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C18H15NO3
Molecular Weight 293.31
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance Pale Yellow to Off-White Powder
Purity / Analysis Method ≥98.0% (HPLC)
Moisture (K.F) ≤1.0%
Specific Rotation -20.0° ~ -26.0° (C=1 DMF)
Test Standard Enterprise Standard
Usage Indacaterol Maleate (CAS: 753498-25-8) Intermediate 

Package & Storage:

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

10

FAQ:

121

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone (CAS: 173140-90-4) with high quality. It is an intermediate typically in the synthesis of Indacaterol Maleate (CAS: 753498-25-8). 

Indacaterol Maleate (CAS: 753498-25-8) is a new, ultra-long-acting, rapid onset β(2)-adrenoceptor agonist and bronchodilator. It is used in the treatment of chronic obstructive pulmonary disease (COPD) and asthma. The European Medicines Agency (EMA) approved indacaterol as a drug in 2009 under the Onbrez trade name while in the United States the Food and Drug Administration approved it under the trade name Arcapta in 2011. The drug is manufactured as its maleate salt form. Also, indacaterol is a chiral molecule; however, only the pure R-enantiomer is distributed. It needs to be taken only once a day, unlike competitors formoterol and salmeterol. 

  • Write your message here and send it to us